Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot Continue reading @biorxiv.org | 1 year ago
Endonuclease fingerprint indicates a synthetic origin of SARS-CoV-2 Continue reading @biorxiv.org | 1 year ago
Role of spike in pathogenic and antigenic behavior of SARS-CoV-2 BA.11 Omicron [pdf] Continue reading @biorxiv.org | 1 year ago
Transcriptomic diversity of cell types across the adult human brain Continue reading @biorxiv.org | 1 year ago
Researchers engineer SARS-CoV-2 Omicron variant with 80% mortality rate Comments | Continue reading @biorxiv.org | 1 year ago
Monkeypox virus shows potential to infect diverse range of native animal species Continue reading @biorxiv.org | 1 year ago
Semantic reconstruction of continuous language from non-invasive brain recording Comments | Continue reading @biorxiv.org | 1 year ago
Modeling the Effect of Background Sounds on Focus with Brain Decoding Technology [pdf] Continue reading @biorxiv.org | 1 year ago
Primary production in groundwater rivals that in oligotrophic marine systems Continue reading @biorxiv.org | 1 year ago
Robust enhancement of motor sequence learning with 4mA transcranial stimulation Continue reading @biorxiv.org | 1 year ago
Robust deep learning based protein sequence design using ProteinMPNN Continue reading @biorxiv.org | 1 year ago
Virological Characteristics of Omicron Variants and BA.2.12.1, BA.4, BA.5 Continue reading @biorxiv.org | 1 year ago
SARS2 infects the Neurons before it is seen in the Blood Comments | Continue reading @biorxiv.org | 1 year ago
High Concentrations of Floating Life in the North Pacific Garbage Patch Continue reading @biorxiv.org | 1 year ago
In vitro neurons learn and exhibit sentience when embodied in a simulated world Continue reading @biorxiv.org | 2 years ago
Inhalable textile microplastic fibers impair lung repair Comments | Continue reading @biorxiv.org | 2 years ago
Human papillomavirus integration transforms chromatin to drive oncogenesis Continue reading @biorxiv.org | 2 years ago
Evolution of antibodies from general protein language models and sequence alone Continue reading @biorxiv.org | 2 years ago
Omicron breakthrough infection drives cross-variant neutralization Continue reading @biorxiv.org | 2 years ago
Humoral and cellular immune memory to four Covid-19 vaccines Continue reading @biorxiv.org | 2 years ago
First evidence of divergent Covid lineage in deer and deer-to-human transmission Continue reading @biorxiv.org | 2 years ago
Nematodes can survive in a suspended form of life for indefinite time Continue reading @biorxiv.org | 2 years ago
Rejuvenation of aged tissues by a single cycle of transient reprogramming [pdf] Continue reading @biorxiv.org | 2 years ago
Neo-CoV, a close relative of MERS-CoV (35% fatality rate) discovered Continue reading @biorxiv.org | 2 years ago
Self-replicating radiation-shield for deep-space exploration: Radiotrophic fungi Continue reading @biorxiv.org | 2 years ago
In vitro neurons learn and exhibit sentience when embodied in a game-world Continue reading @biorxiv.org | 2 years ago
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant Continue reading @biorxiv.org | 2 years ago
Extensive recombination-driven coronavirus diversification[,,,] Continue reading @biorxiv.org | 2 years ago
SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response Continue reading @biorxiv.org | 2 years ago
SARS-CoV-2 escape in vitro from highly neutralizing Covid-19 convalescent plasma Continue reading @biorxiv.org | 2 years ago
Drag-and-drop genome insertion without DNA cleavage with CRISPR Continue reading @biorxiv.org | 2 years ago
Outsourced hearing in spiders by using their webs as auditory sensors Continue reading @biorxiv.org | 2 years ago
Ineffective neutralization of the Mu variant by convalescent and vaccine sera [pdf] Continue reading @biorxiv.org | 2 years ago
Nematode worms choose between bacterial foods as if maximizing economic utility Continue reading @biorxiv.org | 2 years ago
Delta variant poised to acquire complete resistance to wild-type spike vaccines [pdf] Continue reading @biorxiv.org | 2 years ago
SARS-CoV-2 Delta poised to acquire resistance to wild-type spike vaccines [pdf] Continue reading @biorxiv.org | 2 years ago
Delta variant will acquire complete resistance to wild-type spike vaccines Continue reading @biorxiv.org | 2 years ago
SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance Continue reading @biorxiv.org | 2 years ago
Single-sequence protein structure prediction using language models Continue reading @biorxiv.org | 2 years ago
SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance Continue reading @biorxiv.org | 2 years ago